Treace Medical Concepts, Inc. (TMCI)

Market Cap	574.82M
Revenue (ttm)	174.68M
Net Income (ttm)	-47.66M
Shares Out	61.68M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	995,796
Open	9.12
Previous Close	8.95
Day's Range	8.83 - 9.14
52-Week Range	5.27 - 27.97
Beta	0.17
Analysts	Strong Buy
Price Target	18.92 (+112.35%)
Earnings Date	Nov 9, 2023

About TMCI

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system desi...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 23, 2021
• Employees: 423
• Stock Exchange: NASDAQ
• Ticker Symbol: TMCI

Financial Performance

In 2022, TMCI's revenue was $141.84 million, an increase of 50.22% compared to the previous year's $94.42 million. Losses were -$42.82 million, 106.4% more than in 2021.

Analyst Forecast

According to 6 analysts, the average rating for TMCI stock is "Strong Buy." The 12-month stock price forecast is $18.92, which is an increase of 112.35% from the latest price.

Price Target

$18.92

(112.35% upside)

Analyst Consensus: Strong Buy